Literature DB >> 18059319

Oxytocin stimulates migration and invasion in human endothelial cells.

M G Cattaneo1, B Chini, L M Vicentini.   

Abstract

BACKGROUND AND
PURPOSE: It has recently been reported that oxytocin is produced by some tumour cell types, and that oxytocin receptors, belonging to the G-protein-coupled receptor (GPCR) family, are expressed in a variety of cell types. Among these, human umbilical vein endothelial cells (HUVECs) respond to oxytocin with an increased proliferation, suggesting a possible role for the hormone in the regulation of angiogenesis. EXPERIMENTAL APPROACH: We employed chemotaxis and chemoinvasion assays to characterize the effect of oxytocin on HUVEC motility, and immunoblot analysis to study its molecular mechanisms of action. KEY
RESULTS: We showed that oxytocin stimulates migration and invasion in HUVECs via oxytocin receptor activation. Searching for the molecular mechanism(s) responsible for oxytocin's pro-migratory effect, we identified the Gq coupling of oxytocin receptors and phospholipase C (PLC) as the main effectors of oxytocin's action in HUVECs. We also found that oxytocin stimulates the phosphorylation of endothelial nitric oxide synthase (eNOS) via the phosphatidylinositol-3-kinase (PI-3-K)/AKT pathway, and that the activation of PI-3-K and formation of nitric oxide (NO) are required for the pro-migratory effect of oxytocin. CONCLUSIONS AND IMPLICATIONS: The ability of oxytocin to stimulate HUVEC motility and invasion suggests that the hormone can participate in physiopathological processes where activation of endothelial cells plays an important role, for example, in angiogenesis. Interestingly, both the AKT and eNOS phosphorylation induced by oxytocin receptor activation depended on PLC activity, thus suggesting the existence of a still undefined mechanism connecting PLC to the PI-3-K/AKT pathway, upon oxytocin stimulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18059319      PMCID: PMC2259201          DOI: 10.1038/sj.bjp.0707609

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

Review 1.  Dancing to the tune of chemokines.

Authors:  M Thelen
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

2.  Hormones and calcium: mechanisms controlling uterine smooth muscle contractile activity. The Litchfield Lecture.

Authors:  B M Sanborn
Journal:  Exp Physiol       Date:  2001-03       Impact factor: 2.969

Review 3.  Angiogenesis in the female reproductive organs: pathological implications.

Authors:  Lawrence P Reynolds; Anna T Grazul-Bilska; Dale A Redmer
Journal:  Int J Exp Pathol       Date:  2002-08       Impact factor: 1.925

Review 4.  The oxytocin receptor system: structure, function, and regulation.

Authors:  G Gimpl; F Fahrenholz
Journal:  Physiol Rev       Date:  2001-04       Impact factor: 37.312

Review 5.  Bioactive lysophospholipids and their G protein-coupled receptors.

Authors:  W H Moolenaar
Journal:  Exp Cell Res       Date:  1999-11-25       Impact factor: 3.905

6.  Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability.

Authors:  D Fukumura; T Gohongi; A Kadambi; Y Izumi; J Ang; C O Yun; D G Buerk; P L Huang; R K Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

7.  Activation of functional oxytocin receptors stimulates cell proliferation in human trophoblast and choriocarcinoma cell lines.

Authors:  P Cassoni; A Sapino; L Munaron; S Deaglio; B Chini; A Graziani; A Ahmed; G Bussolati
Journal:  Endocrinology       Date:  2001-03       Impact factor: 4.736

8.  Oxytocin is a growth factor for Kaposi's sarcoma cells: evidence of endocrine-immunological cross-talk.

Authors:  Paola Cassoni; Anna Sapino; Silvia Deaglio; Benedetta Bussolati; Marco Volante; Luca Munaron; Adriana Albini; Antonietta Torrisi; Gianni Bussolati
Journal:  Cancer Res       Date:  2002-04-15       Impact factor: 12.701

9.  Localization of the human oxytocin receptor in caveolin-1 enriched domains turns the receptor-mediated inhibition of cell growth into a proliferative response.

Authors:  Francesca Guzzi; Deborah Zanchetta; Paola Cassoni; Valeria Guzzi; Maura Francolini; Marco Parenti; Bice Chini
Journal:  Oncogene       Date:  2002-03-07       Impact factor: 9.867

Review 10.  Agonist selectivity in the oxytocin/vasopressin receptor family: new insights and challenges.

Authors:  B Chini; M Manning
Journal:  Biochem Soc Trans       Date:  2007-08       Impact factor: 5.407

View more
  23 in total

1.  Oxytocin increases invasive properties of endometrial cancer cells through phosphatidylinositol 3-kinase/AKT-dependent up-regulation of cyclooxygenase-1, -2, and X-linked inhibitor of apoptosis protein.

Authors:  Marie-Claude Déry; Parvesh Chaudhry; Valérie Leblanc; Sophie Parent; Anne-Marie Fortier; Eric Asselin
Journal:  Biol Reprod       Date:  2011-08-03       Impact factor: 4.285

2.  The hypothalamic neuropeptide oxytocin is required for formation of the neurovascular interface of the pituitary.

Authors:  Amos Gutnick; Janna Blechman; Jan Kaslin; Lukas Herwig; Heinz-Georg Belting; Markus Affolter; Joshua L Bonkowsky; Gil Levkowitz
Journal:  Dev Cell       Date:  2011-10-18       Impact factor: 12.270

3.  Endothelium in pharmacology: 30 years on.

Authors:  J C McGrath
Journal:  Br J Pharmacol       Date:  2009-06       Impact factor: 8.739

4.  Cannabidiol inhibits angiogenesis by multiple mechanisms.

Authors:  M Solinas; P Massi; A R Cantelmo; M G Cattaneo; R Cammarota; D Bartolini; V Cinquina; M Valenti; L M Vicentini; D M Noonan; A Albini; D Parolaro
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

5.  Subchronic treatment of rats with oxytocin results in improved adipocyte differentiation and increased gene expression of factors involved in adipogenesis.

Authors:  Miroslava Eckertova; Maria Ondrejcakova; Katarina Krskova; Stefan Zorad; Daniela Jezova
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

6.  Peri-Infarct Upregulation of the Oxytocin Receptor in Vascular Dementia.

Authors:  Erin C McKay; John S Beck; Sok Kean Khoo; Karl J Dykema; Sandra L Cottingham; Mary E Winn; Henry L Paulson; Andrew P Lieberman; Scott E Counts
Journal:  J Neuropathol Exp Neurol       Date:  2019-05-01       Impact factor: 3.685

7.  Effect of oxytocin on neuroblastoma cell viability and growth.

Authors:  Jan Bakos; Vladimir Strbak; Nina Ratulovska; Zuzana Bacova
Journal:  Cell Mol Neurobiol       Date:  2012-01-18       Impact factor: 5.046

8.  Orphan nuclear receptor TR3/Nur77 improves wound healing by upregulating the expression of integrin β4.

Authors:  Gengming Niu; Taiyang Ye; Liuliang Qin; Pierre M Bourbon; Cheng Chang; Shengqiang Zhao; Yan Li; Lei Zhou; Pengfei Cui; Issac Rabinovitz; Arthur M Mercurio; Dezheng Zhao; Huiyan Zeng
Journal:  FASEB J       Date:  2014-10-17       Impact factor: 5.191

9.  Oxytocin induces the migration of prostate cancer cells: involvement of the Gi-coupled signaling pathway.

Authors:  Miao Zhong; Maryam L Boseman; Ana C Millena; Shafiq A Khan
Journal:  Mol Cancer Res       Date:  2010-07-27       Impact factor: 5.852

10.  Oxytocin-Gly-Lys-Arg: a novel cardiomyogenic peptide.

Authors:  Bogdan A Danalache; Jolanta Gutkowska; Magdalena J Slusarz; Irena Berezowska; Marek Jankowski
Journal:  PLoS One       Date:  2010-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.